Decitabine Improves Outcomes in Older Patients with Acute Myeloid Leukemia (AML) and Higher Blast Counts

Eitemau Tebyg

• Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia()()
  gan: Delaunay, Jacques, et al.
  Cyhoeddwyd: (2013)
• Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia
  gan: Arthur, Christopher, et al.
  Cyhoeddwyd: (2015)
• Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics
  gan: Mayer, Jiří, et al.
  Cyhoeddwyd: (2014)
• PROGRESS IN ACUTE MYELOID LEUKEMIA
  gan: Kadia, Tapan M., et al.
  Cyhoeddwyd: (2014)
• Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  gan: Kantarjian, Hagop M., et al.
  Cyhoeddwyd: (2012)